Emergent Biosolutions, Inc. (EBS) financial statements (2020 and earlier)

Company profile

Business Address 400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG, MD 20879
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments168112178272313280179
Cash and cash equivalents168112178272313280179
Restricted cash and investments001    
Receivables2752711461481276061
Inventory, net of allowances, customer advances and progress billings22320614374776615
Inventory22320614374776615
Deferred costs 1     
Income taxes receivable6
Other undisclosed current assets20301716222613
Total current assets:686621485510539432273
Noncurrent Assets
Property, plant and equipment542510407376332314264
Intangible assets, net (including goodwill)9801,0211697511210044
Goodwill2672604941554214
Intangible assets, net (excluding goodwill)71376212034575830
Other noncurrent assets771462783
Other undisclosed noncurrent assets426336549142
Total noncurrent assets:1,6411,609585460505513354
TOTAL ASSETS:2,3272,2291,0709701,044945627
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1971748476877953
Accounts payable95814235464128
Accrued liabilities403156661
Employee-related liabilities62583835353225
Taxes payable 5     
Debt1310 20   
Deferred revenue and credits137852
Contract with customer, liability11
Other liabilities4      
Other undisclosed current liabilities3623591
Total current liabilities:2162001001061009357
Noncurrent Liabilities
Long-term debt and lease obligation7987851324825325162
Long-term debt, excluding current maturities7987851324825325162
Liabilities, other than long-term debt1341793410872
Deferred revenue and credits17876 
Accounts payable and accrued liabilities 1113    
Contract with customer, liability8663
Deferred tax liabilities, net68     
Other liabilities493852112
Other undisclosed noncurrent liabilities90541010234117
Total noncurrent liabilities:1,0231,0185826828429981
Total liabilities:1,2391,219158374384392137
Stockholders' equity
Stockholders' equity attributable to parent1,0891,011912596660553490
Common stock0000000
Treasury stock, value(40)(40)(39)(6)(6)(6)(6)
Additional paid in capital716689618352318274248
Accumulated other comprehensive loss(10)(6)(4)(4)(3)(3)(3)
Retained earnings422367337254351288252
Stockholders' equity attributable to noncontrolling interest      (0)
Total stockholders' equity:1,0891,011912596660553489
TOTAL LIABILITIES AND EQUITY:2,3272,2291,0709701,044945627

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues1,106782561489523450313
Revenue, net561489523450313
Cost of revenue
(Cost of Goods and Services Sold)
(434)(322)(196)(131)(124)(118)(62)
Gross profit:673460365357398332251
Operating expenses(992) (241)(252)(302)(298)(212)
Other undisclosed operating income (loss)434(370)   244
Operating income:11490124106965843
Nonoperating income (expense)(37)(8)(6)(6)(6)(5)1
Investment income, nonoperating  21100
Other nonoperating income (expense)22(1)0(0)30
Interest and debt expense(38)(10)(7)(8)(7)(8) 
Other undisclosed income from continuing operations before equity method investments, income taxes38107878 
Income from continuing operations before income taxes:778211999905343
Income tax expense(23)(19)(36)(37)(27)(16)(13)
Income from continuing operations:55638363633730
Loss from discontinued operations   (11)   
Net income:55638352633730
Net income attributable to noncontrolling interest      1
Net income available to common stockholders, basic:55638352633731
Interest on convertible debt   333 
Net income available to common stockholders, diluted:55638355664031

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income:55638352633730
Other comprehensive loss(0)(2)     
Other undisclosed comprehensive income (loss)  1(2)002
Comprehensive income:54618350633732
Comprehensive loss, net of tax, attributable to noncontrolling interest      (1)
Other undisclosed comprehensive loss, net of tax, attributable to parent(4)      
Comprehensive income, net of tax, attributable to parent:50618350633731

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: